Automated Measurement of Cerebral Hemorrhagic Contusions and Outcomes After Traumatic Brain Injury in the TRACK-TBI Study.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

Because withdrawal of life-sustaining therapy based on perceived poor prognosis is the most common cause of death after moderate or severe traumatic brain injury (TBI), the accuracy of clinical prognoses is directly associated with mortality. Although the location of brain injury is known to be important for determining recovery potential after TBI, the best available prognostic models, such as the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) score, do not currently incorporate brain injury location. To test whether automated measurement of cerebral hemorrhagic contusion size and location is associated with improved prognostic performance of the IMPACT score. This prognostic cohort study was performed in 18 US level 1 trauma centers between February 26, 2014, and August 8, 2018. Adult participants aged 17 years or older from the US-based Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study with moderate or severe TBI (Glasgow Coma Scale score 3-12) and contusions detected on brain computed tomography (CT) scans were included. The data analysis was performed between January 2023 and February 2024. Labeled contusions detected on CT scans using Brain Lesion Analysis and Segmentation Tool for Computed Tomography (BLAST-CT), a validated artificial intelligence algorithm. The primary outcome was a Glasgow Outcome Scale-Extended (GOSE) score of 4 or less at 6 months after injury. Whether frontal or temporal lobe contusion volumes improved the performance of the IMPACT score was tested using logistic regression and area under the receiver operating characteristic curve comparisons. Sparse canonical correlation analysis was used to generate a disability heat map to visualize the strongest brainwide associations with outcomes. The cohort included 291 patients with moderate or severe TBI and contusions (mean [SD] age, 42 [18] years; 221 [76%] male; median [IQR] emergency department arrival Glasgow Coma Scale score, 5 [3-10]). Only temporal contusion volumes improved the discrimination of the IMPACT score (area under the receiver operating characteristic curve, 0.86 vs 0.84; P = .03). The data-derived disability heat map of contusion locations showed that the strongest association with unfavorable outcomes was within the bilateral temporal and medial frontal lobes. These findings suggest that CT-based automated contusion measurement may be an immediately translatable strategy for improving TBI prognostic models.

Identifiants

pubmed: 39212991
pii: 2823021
doi: 10.1001/jamanetworkopen.2024.27772
pmc: PMC11365003
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2427772

Références

Lancet Digit Health. 2020 Jun;2(6):e314-e322
pubmed: 33328125
AJR Am J Roentgenol. 1988 May;150(5):1133-42
pubmed: 3258718
Intensive Care Med. 2022 Feb;48(2):201-212
pubmed: 34904191
J Neurosurg. 1983 Nov;59(5):762-74
pubmed: 6619928
Crit Care Med. 2012 May;40(5):1609-17
pubmed: 22511138
Ann Neurol. 2023 Dec;94(6):1008-1023
pubmed: 37470289
N Engl J Med. 2015 Dec 17;373(25):2403-12
pubmed: 26444221
Crit Care Med. 2017 Nov;45(11):1907-1914
pubmed: 29028696
Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322
pubmed: 11545704
J Neurotrauma. 2019 Apr 1;36(7):1136-1146
pubmed: 30226400
J Neurotrauma. 2008 Jun;25(6):629-39
pubmed: 18491950
J Neurotrauma. 2013 Nov 15;30(22):1831-44
pubmed: 23815563
JAMA. 2020 Sep 8;324(10):961-974
pubmed: 32897344
Brain. 2011 Feb;134(Pt 2):449-63
pubmed: 21193486
N Engl J Med. 2016 Sep 22;375(12):1119-30
pubmed: 27602507
Neuroimage. 2012 Jul 16;61(4):957-65
pubmed: 22440645
JAMA Surg. 2020 Aug 1;155(8):723-731
pubmed: 32584926
J Neurotrauma. 2012 Jan 1;29(1):19-31
pubmed: 21988198
PLoS Med. 2008 Aug 5;5(8):e165; discussion e165
pubmed: 18684008
Med Image Anal. 2017 Feb;36:61-78
pubmed: 27865153
J Neurosurg. 2011 Nov;115(5):1019-24
pubmed: 21780860
Neuropsychologia. 2018 Jul 1;115:154-166
pubmed: 28882479
JAMA Neurol. 2021 Aug 1;78(8):982-992
pubmed: 34228047
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Curr Opin Neurobiol. 2013 Apr;23(2):250-4
pubmed: 23146876
J Head Trauma Rehabil. 2004 Jul-Aug;19(4):314-28
pubmed: 15263859
Brain. 2021 Feb 12;144(1):92-113
pubmed: 33257929
Hum Brain Mapp. 2020 Apr 15;41(6):1520-1531
pubmed: 31904898
Hum Brain Mapp. 2017 Mar;38(3):1692-1701
pubmed: 28045225
N Engl J Med. 2012 Dec 27;367(26):2471-81
pubmed: 23234472
Nat Commun. 2019 Aug 2;10(1):3497
pubmed: 31375668
J Neurotrauma. 2019 Nov 15;36(22):3158-3163
pubmed: 31210093
Brain Pathol. 1995 Oct;5(4):397-406
pubmed: 8974622
Ann Neurol. 2018 Dec;84(6):926-930
pubmed: 30421457
JAMA Neurol. 2021 Sep 1;78(9):1137-1148
pubmed: 34279565
Intensive Care Med. 2022 Mar;48(3):386
pubmed: 35059778
Sci Data. 2019 Oct 30;6(1):244
pubmed: 31666530
JAMA Netw Open. 2023 Mar 1;6(3):e233660
pubmed: 36939699
Brain. 2022 May 24;145(4):1338-1353
pubmed: 35025994
Neuroimage Clin. 2017 Feb 15;14:379-390
pubmed: 28275541
J Neurotrauma. 1992 Mar;9 Suppl 1:S287-92
pubmed: 1588618
Neurotrauma Rep. 2023 Mar 01;4(1):118-123
pubmed: 36895818
Neurocrit Care. 2021 Feb;34(1):312-324
pubmed: 32462411
N Engl J Med. 1986 Apr 10;314(15):953-8
pubmed: 3960059
CMAJ. 2011 Oct 4;183(14):1581-8
pubmed: 21876014
MDM Policy Pract. 2018 Mar 26;3(1):2381468318757987
pubmed: 30288437
Brain. 2023 Apr 19;146(4):1672-1685
pubmed: 36181425
Crit Care Med. 2021 Aug 1;49(8):1322-1332
pubmed: 33730742
Neurology. 2022 Mar 22;98(12):e1248-e1261
pubmed: 35173018

Auteurs

Samuel B Snider (SB)

Division of Neurocritical Care, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Nancy R Temkin (NR)

Department of Neurological Surgery, University of Washington, Seattle.
Department of Biostatistics, University of Washington, Seattle.

Xiaoying Sun (X)

Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego.

Jacob L Stubbs (JL)

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Quinn J Rademaker (QJ)

Division of Neurocritical Care, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.

Amy J Markowitz (AJ)

Department of Neurological Surgery, University of California, San Francisco.

Eric S Rosenthal (ES)

Harvard Medical School, Boston, Massachusetts.
Division of Clinical Neurophysiology, Department of Neurology, Massachusetts General Hospital, Boston.

Ramon Diaz-Arrastia (R)

Department of Neurology, University of Pennsylvania, Philadelphia.

Michael D Fox (MD)

Harvard Medical School, Boston, Massachusetts.
Center for Brain Circuit Therapeutics, Departments of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown.

Geoffrey T Manley (GT)

Department of Neurological Surgery, University of California, San Francisco.
Brain and Spinal Cord Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California.

Sonia Jain (S)

Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego.

Brian L Edlow (BL)

Harvard Medical School, Boston, Massachusetts.
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown.
Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH